1398571-41-9Relevant academic research and scientific papers
Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
-
, (2016/08/17)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.
Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
-
Paragraph 0461; 0462, (2015/06/17)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.
DISPIROPYRROLIDINE DERIVATIVES
-
Page/Page column 158, (2012/10/23)
A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.
